Navigation Links
Inverness Medical Innovations Announces Third Quarter 2008 Results
Date:10/29/2008

neral and

administrative 77,243 (14,393)(b)( c )(d) 62,850

Total operating expenses 266,773 (184,928) 81,845

Operating income (loss) (156,475) 198,866 42,391

Interest and other income

(expense), net (26,898) (26,898)

Income tax (benefit)

provision (1,645) 3,449(g) 1,804

Equity earnings of

unconsolidated entities,

net of tax 1,116 112(b) 1,228

Net (loss) income $(180,612) $195,529 $14,917

Preferred stock dividends $- $-

Net (loss) income

available to common

stockholders - basic $(180,612) $14,917

Net (loss) income per

common share

Basic $(3.74) $0.31

Diluted $(3.74)(h) $0.29(j)

Weighted average common

shares - basic 48,256 48,256

Weighted average common

shares - diluted 48,256(h) 51,483(j)

(a) In calculating net income or loss on an adjusted cash basis, the

Company excludes from net income or loss (i) certain non-cash

charges, including amortization expense and stock-based compensation

expense, (ii) non-recurring charges and income, and (iii) certain

other charges and income that have a significant positive or

negative impact on results yet do not occur on a consistent or

regular basis in its business. In determining whether a particular

item meets one of these criteria, management considers facts and

circumstances that it believes are relevant. Management believes

that
'/>"/>

SOURCE Inverness Medical Innovations, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related biology technology :

1. Inverness Medical Innovations Schedules Conference Call for 10:00 a.m. ET October 29, 2008 to Discuss Third Quarter 2008 Results
2. Inverness Medical Innovations to Present at the UBS Global Life Sciences Conference on September 22, 2008
3. Inverness Medical Innovations to Attend the Goldman Sachs Diagnostics Conference on September 18, 2008
4. Inverness Medical Innovations Declares Dividend on its Series B Convertible Perpetual Preferred Stock
5. Inverness Medical Innovations to Present at the Morgan Stanley Global Healthcare Unplugged Conference on September 9, 2008
6. Inverness Medical Innovations Features Innovative TB Diagnostic - Clearview(R) TB ELISA at AIDS 2008
7. Inverness Medical Innovations to Present at Canaccord Adams 28th Annual Growth Conference on August 12, 2008
8. Inverness Medical Innovations Announces Second Quarter 2008 Results
9. Inverness Medical Innovations to Present at Jefferies 2nd Annual Healthcare Conference held on June 25, 2008
10. Inverness Medical Innovations to Present at 7th Annual Needham & Company, LLC Biotechnology & Medical Technology Conference on June 12, 2008
11. Inverness Medical Innovations to Present at FBR Capital Markets 12th Annual Spring Investor Conference on May 28, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... ... September 01, 2015 , ... ... University of California Los Angeles, Boston University School of Medicine, Frederick National Laboratory ... PLOS One, the world’s first multidisciplinary Open Access journal. , Christopher Ryan ...
(Date:8/31/2015)... ON , Aug. 31, 2015 /PRNewswire/ - BIOREM Inc. ... orders totalling $5.7 million. The orders are for air emission abatement ... "Of particular note is a large order for a municipality ... equipment will be replacing a competitor,s system that failed to ... in our engineered solutions," said Derek S. Webb , ...
(Date:8/31/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/k6lcp2/mexico_biomedical ) has announced ... - Growth, Trends & Forecasts (2014-2020)" report to ... Sensors market is estimated at $0.20 billion by 2018 ... The near future will bring biomedical sensors ... individual. These sensors can be set to trigger alerts ...
(Date:8/31/2015)... TORONTO , Aug. 31, 2015 /PRNewswire/ - Portage ... Canadian Securities Exchange: PBT.U), is pleased to announce that ... be advancing its lead candidate, PPL-003, to an Investigational ... dry eye disease and uveitis.  PPL recently completed a ... where topical PPL-003 solution achieved highly significant efficacy and ...
Breaking Biology Technology:Synedgen’s Director for Pharmaceutical Manufacturing Publishes New Research 2Synedgen’s Director for Pharmaceutical Manufacturing Publishes New Research 3Mexico Biomedical Sensors Market Report 2015-2020 2Portage's PPL will advance its lead candidate PPL-003 to an IND for dry eye disease and uveitis 2Portage's PPL will advance its lead candidate PPL-003 to an IND for dry eye disease and uveitis 3
... SAN DIEGO, April 28, 2011 Genomatica ... Chemical Corporation , the eighth-largest chemical maker in the world, ... areas of collaboration.  These include: , Study of ... production in Asia :  Mitsubishi and Genomatica ...
... Qteros, Inc., the developer of a unique and highly ... lowest-cost production of cellulosic ethanol, today announced its plans ... of May. Kevin A. Gray, Ph.D., Senior ... deliver an oral presentation at the 33rd Symposium on ...
... The Center for Business Intelligence (CBI), a division of ... Children,s Rare Disease Network and The Global Genes Project for ... 12 - 13, 2011 at the Doubletree Hotel in Washington, ... They affect few people individually, but there are more than ...
Cached Biology Technology:Mitsubishi Chemical Corporation Signs Memorandum of Understanding for Strategic Partnership With Genomatica for Sustainable Chemicals in Asia 2Mitsubishi Chemical Corporation Signs Memorandum of Understanding for Strategic Partnership With Genomatica for Sustainable Chemicals in Asia 3Qteros Management to Present at Upcoming Conferences in May 2CBI Announces Partnership With Children's Rare Disease Network and The Global Genes Project 2CBI Announces Partnership With Children's Rare Disease Network and The Global Genes Project 3
(Date:7/31/2015)... La 10 th International Conference on Genomics ... 22 al 25 de octubre de 2015 en ... conferencia celebra su décimo aniversario. Desde su inauguración en el ... reuniones anuales más influyentes del mundo en el campo ,ómico, ... y mejores a nivel científico. ICG-10 se ...
(Date:7/31/2015)... Jul. 31, 2015 NXT-ID, Inc. (NASDAQ: NXTD ... focused on the growing mobile commerce market and creator ... filed provisional patent 62/198989 for ELECTRONIC CRYPTO-CURRENCY ... a method to advance crypto-currencies such as Bitcoin into ... common, uniform way to manage all payments.  ...
(Date:7/30/2015)... MOUNTAIN VIEW, Calif. , July 30, 2015 ... products and services for gene function analysis and ... CRISPR Guide RNA (sgRNA) Knockout Library targeting all ... to specifically and permanently "knock out" a gene,s ... library provides a high throughput screening tool so ...
Breaking Biology News(10 mins):La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 2La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 3NXT-ID Patents Electronic Crypto-Currency Management Technology 2NXT-ID Patents Electronic Crypto-Currency Management Technology 3NXT-ID Patents Electronic Crypto-Currency Management Technology 4CELLECTA, INC. Announces Launch of Human Whole Genome CRISPR Knockout Library 2
... Genome Project at Penn State University, with an ... to Charles Darwin's "abominable mystery:" the inexplicably rapid ... appearance some 140 million years ago. By ... sequences from thirteen strategically selected plant species, the ...
... an important role in the formation of gold nuggets ... in the international journal, Science .. , The ... for Landscape Environments and Mineral Exploration (CRC LEME) project ... has shown that bacteria play a significant role in ...
... Medical School researchers have discovered one way that a ... of chronically infected cystic fibrosis (CF) patients. ... as Pseudomonas aeruginosa (PA) use protein secretion systems to ... author of the study published in the June 9 ...
Cached Biology News:Massive duplication of genes may solve Darwin's 'abominable mystery' about flowering plants 2Massive duplication of genes may solve Darwin's 'abominable mystery' about flowering plants 3Massive duplication of genes may solve Darwin's 'abominable mystery' about flowering plants 4The Midas Bug -- the bacterial alchemy of gold 2Discovery could aid fight against cystic fibrosis infection 2
BD Primaria 35 mm Cell Culture Dish with Easy-Grip design, surface-modified polystyrene for enhanced cell culture. (20/sp, 200/ca) Packaging: 20 / sleeve, 500 / case ...
... of ICE-family proteases/caspases initiates apoptosis in mammalian ... Detection Kit provides a simple and convenient ... flow cytometry in intact cells. The ... aspartate residues linked to rhodamine 110 (D2R), ...
...
The PROTEAN II slab gel casting stand is a component of the PROTEAN II XL and xi casting apparatus. It is supplied with gaskets....
Biology Products: